期刊文献+

运动康复在射血分数保留的心力衰竭伴房颤患者中的应用效果 被引量:12

下载PDF
导出
摘要 流行病学[1]表明,心力衰竭(CHF)中至少50%的患者左室收缩功能正常。CHF的症状是由于左室舒张功能障碍所致,即为左室射血分数保留心力衰竭(HFPEF),左室射血分数正常或接近正常,并排除其他瓣膜性心脏病的一组临床综合征。HFPEF常合并房颤,其发生率高达30-40%[2]。大量研究[3]表明,运动康复对心力衰竭患者是安全的,可以提高患者的运动耐量、生活质量,最终改善患者预后。
作者 蒋埜 颜紫宁
出处 《实用临床医药杂志》 CAS 2016年第17期173-174,共2页 Journal of Clinical Medicine in Practice
  • 相关文献

参考文献15

  • 1Wang J,Nagueh S F.Current perspectives on cardiac function in patients with diastolic heart failure[J].Circulation,2009,119:1 146-1157.
  • 2李清,陈海燕,周年伟,舒先红,潘翠珍,葛均波.斑点追踪技术评价左心室射血分数正常心力衰竭伴心房颤动患者左心室收缩功能[J].中华超声影像学杂志,2014,23(11):930-933. 被引量:10
  • 3Boudreau M,Genoesse J.Cardiac rehabilitation:a comprehensive program for the management of heart failure[J].Prog Cardiovasc Nurs,2007,22(2):88-92.
  • 4射血分数正常心力衰竭诊治的中国专家共识组.射血分数正常心力衰竭诊治的中国专家共识[J].中国医刊,2010,45:63-67.
  • 5Cleland JG,Tendera M,Adamus J,et al.The perindopril in elderly people with chronic heart failure(PEP-CHF)study[J].Eur Heart J,2006,27:2338-2345.
  • 6Yusuf S,Pfeffer M A,Swedberg K,et al.Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction:the CHARM-preserved trial[J].Lancet,2003,362:777-781.
  • 7Massie B M,Carson P E,Mc Murray J J,et al.Irbesartan in patients with heart failure and preserved ejection fraction[J].Nengl J Med,2008,359:2456-2467.
  • 8Yamamoto K,Origasa H,Hori M.Effects of carvedilol on heart failure with preserved ejection fraction:the Japanese diastolic heart failure study(J-DHF)[J].Eur J Heart Fail,2013,15:110-118.
  • 9Keteyian SJ,Pifia IL,Hibner BA,et al.Clinical role of exercise training in the management of patients with chronic heart failure[J].J Cardiopulm Rehabil Prey,2010,30:67-76.
  • 10李悦.心房颤动与心房结构重构[J].中国心脏起搏与心电生理杂志,2003,17(3):227-229. 被引量:15

二级参考文献42

  • 1裴晓阳,徐亚伟,于学靖,朱梦云.卡维地洛对慢性心力衰竭患者血浆脑钠素水平的影响[J].临床心血管病杂志,2005,21(8):468-469. 被引量:4
  • 2徐倩,商永芳,袁鹰,苗志敏.脑利尿钠肽与早期糖尿病肾病的关系[J].齐鲁医学杂志,2006,21(2):144-145. 被引量:3
  • 3European Study Group on Diastolic Heart Failure. How to diagnose diastolic heart failure[J]. Eur Heart, 1998,19(7): 990-1003.
  • 4KATZ A M, ZILE M R. New molecular mechanism in diastolic heart failure[J]. Circulation JT Circulation, 2006,113 (16) :1922-1925.
  • 5PEMBERTON C J, JOHNSON M L, YANDLE T G, et al. Deconvolution analysis of cardiac natriuretic peptides during acute volume overload[J]. Hypertension, 2000,36 : 36 (3): 355-359.
  • 6MUELLER T, GEGENHUBER A, POELZ W, et al. Head to head comparison of the diagnostic utility of BNP and NT proBNP in symptomatic and asymptomatic structural heart disease[J]. ClinChim Acta, 2004:341(1-2) :41- 48.
  • 7TSCHOPE C, KASNER M, WESTERMANN D, et al. The role of NT proBNP in the diagnostics of isolated diastolic dysfunction:correlation with echocardiographic and invasive measurements[J]. Eur Heart J , 2005:26(21):2277-2284.
  • 8NAKAO S, GODA A, YUBA M, et al. Characterization of left ventricular filling abnormalities and its relation to elevated plasma brain natriuretic peptide level in acute to chronic diastolic heart failure[J]. Circ J JT-Circulation Journal of Ficial Journal of the Japanese Circulation Society, 2007, 71 ( 9 ) : 1412 -1417.
  • 9McDONAGH T A, HOLMER S, RAYMOND I, et al. NT-proBNP and the diagnosis of heart failure: a pooled analysis of three European epidemiological studies[J]. EurJ Heart Fail, 2004,6(3) :269- 273.
  • 10SIVAKUMAR R, WELLSTED D, PARKER K, et al. Utility of N terminal pro brain natriuretic peptide in elderly patients [J]. PostgradMed J JT, 2006,82(965):220- 223.

共引文献31

同被引文献135

引证文献12

二级引证文献81

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部